tell you that Adam F. is a short seller and has done similar pieces on Mannkind. The lawsuits have no merit since a link to the original article was provided. In fact, the 96% and 100% data are correct and author recommended Cs in high risk patients. Ignorance is not an excuse or defense, before investing you have to research. The link was provided for all to read.
while the crooks are GS and JPM speculated based on initial script numbers. NOW who would trust?
Afrezza is just too good of a product and Technosphere a revolutionary technology. The new Tesla in biotech. I expect to be a millionaire in a few years. I am all in !!!
Shorts used low script numbers to drive down pps. Now this is baked in the price, they don't care anymore unless the numbers spike up and they will have to cover.
Would a company with 102 million outstanding shares trade only 30-70K share a day? every financial site reporting now 2.5 million outstanding shares, market cap of $1.6 million